See our other webinars
Agenda
- Dysplasia detection in Barrett’s Esophagus - Dr. Marnix Jansen & Dr. David Graham
- Treatment of superficial lesions and management of complications (ESD/EMR) - Dr. Roos Pouw
- Treatment of Barrett’s Esophagus lesions with Barrx™ RFA therapy - Prof. Horst Neuhaus
- Discussion and Q&A - Chaired by Prof. Raf Bisschops
Chair
- Prof. Raf Bisschops
Speakers
- Dr. Marnix Jansen
- Dr. David Graham
- Prof. Horst Neuhaus
- Dr. Roos Pouw
Speaker Biographies
Dr. Marnix Jansen
Marnix Jansen, MD PhD MSc, is a Cancer Research UK (CRUK) Clinician Scientist and Consultant Histopathologist at University College Hospitals London NHS Trust and Associate Professor at UCL Cancer Institute.
Dr Jansen trained in the Academic Medical Center (AMC) in Amsterdam, the Netherlands. He has undertaken combined clinical and research training at the pathology departments of the Johns Hopkins Medical Institutes in Baltimore, USA and the National Cancer Centre Hospital in Tokyo, Japan. After obtaining a Translational Cancer Research Fellowship awarded by the Dutch Cancer Society, he moved to the laboratory of Sir Nicholas Wright at Barts Cancer Institute in London. The work in his research group focuses on stem cell evolution in Barrett’s dysplasia and the preneoplastic stomach and on machine learning in 3D pathology.
Prof. Horst Neuhaus
Horst Neuhaus graduated from the University of Bonn, Germany, in 1979. In the same year he obtained his Doctor of Medicine. He did residencies at the Department of Surgery in Cologne and Departments of Internal Medicine in Neuss and Ingolstadt. After his training in gastroenterology, Professor Neuhaus became faculty member of the Medical Department II of the Technical University Munich under the leadership of Professor Meinhard Classen. In 1987, he became head of the endoscopy unit.
Since 1999 Horst Neuhaus has been Associate Professor at the Medical Faculty of the Technical University Munich. In 1995, Professor Neuhaus was appointed as Chief of the Department of Internal Medicine of the Evangelisches Krankenhaus Düsseldorf, teaching hospital of the University of Düsseldorf. His position includes Chief of Service of the Department of Gastroenterology. As part of it, the tertiary referral endoscopy center was recognized as a WEO Center of Excellence and training center of the ESGE.
Horst Neuhaus has a wide field of clinical and scientific interests which include diagnostic and therapeutic endoscopy, biliary and pancreatic diseases and endoscopic management of early gastrointestinal neoplasms. His group is continuously active in research, participation in studies and publishing in a close cooperation with other centers and the biomedical industry. He is on the editorial board of the several peer-reviewed journals.
Professor Neuhaus has served as councillor of the Governing Board and the Scientific Committee of the UEG and the International Committee of the ASGE. He was previously president of the ESGE and the endoscopy section of the German Society of Gastroenterology (DGVS). He is Honorary President of the German Society of Endoscopy and Imaging Procedures (DGE-BV). He served on the steering committees of previous world congresses of endoscopy (ENDO 2017 and 2020). Professor Neuhaus was recognized as International Honorary member of the Japan Gastroenterological Endoscopy Society (JGES) and as honorary member of other societies. He is director of the annual Düsseldorf International Endoscopy Symposium which was established by his group in 1999.
Dr. David Graham
David Graham is a Consultant Gastroenterologist at University College Hospital, London. He trained at St Bartholomew’s and the Royal London Medical School and completed Gastroenterology training in North East London. He undertook a PhD at UCL focussing on the early detection of esophageal cancer through the utilisation of salivary “liquid biopsies” and artificial intelligence analysis of patient data.
He has a specialist interest in Barrett’s Esophagus, oesophago-gastric cancer, endoscopic imaging technologies and interventional endoscopy. Additionally, he was part of the expert committee devising the BSG guidelines for the management of the pre-malignant and early malignant lesions of the stomach and is part of international research collaborations aiming to improve the early detection of these lesions.
Finally, David has a keen interest in endoscopy training and has helped run many live endoscopy courses at UCH.
Dr. Roos Pouw
Roos Pouw is a gastroenterologist and principal investigator at the department of Gastroenterology & Hepatology at the Amsterdam University Medical Center, The Netherlands. In 2011 Roos obtained her PhD-degree Cum Laude with her thesis entitled "Endoscopic eradication of Barrett's Esophagus with early neoplasia." Next to her clinical work, Roos supervises a number of research lines on endoscopic management of early Barrett's neoplasia, and for this work she received the UEG Rising Star Award 2020. Furthermore, Roos is active as editorial (advisory) board member for the UEG Journal and Best Practice & Research: Clinical Gastroenterology.